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The [Pd(DEEN)Cl2] and [Pt(DEEN)Cl2] complexes were synthesized and characterized where DEEN = N,N-diethyl-
ethylenediamine. The stoichiometry and stability of the complexes formed between various biologically relevant ligands (amino
acids, peptides, DNA constituents and dicarboxylic acids) and [Pd(DEEN)(H2O)2]
2+ were investigated at 37
◦C and 0.16M ionic
strength. The stability constant of the complexes formed in solution were determined and the binding centres of the ligands
were assigned. The concentration distribution diagrams of the complexes were evaluated The equilibrium constants for the
displacement of representative coordinated ligands such as inosine, glycine or methionine by cysteine were calculated and the
concentration distribution diagrams of the various species were evaluated. The kinetics of base hydrolysis of free and coordinated
S-methylcysteine methyl ester was investigated. The mechanism of hydrolysis was discussed.
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1.Introduction
Cis-platin [cis-diamminedichloroplatinum(II)] is one of the
most active antitumour agents in clinical use [1]. However,
it has a narrow spectrum of activity, and its clinical use
is limited by undesirable side eﬀects, including nephro-
toxicity, ototoxicity, neurotoxicity, nausea, vomiting, and
myelosuppression [2, 3]. In the search for new platinum
anticancer drugs, great eﬀorts are devoted to the design of
c o m p l e x e sm o r ee ﬃcient and less toxic than the reference
drugs already in clinical use. For this purpose, the rational
design of complexes and the study of relevant structure-
activity relationships have been extended to families of new
compounds having high structural diversity.
Pd(II) and Pt(II) amine complexes have the same struc-
ture, with a ﬁve orders of magnitude higher reactivity in the
caseofPd(II)complexes,butsimilarthermodynamicparam-
eters. Pd(II) complexes are good models for the analogous
Pt(II)complexesinsolution. Recentworkinourlaboratories
focused on the equilibria of complex-formation reactions of
cis-(diamine)palladium(II) complexes with DNA, the major
target in chemotherapy of tumours, and biorelevant ligands
as amino acids, peptides, dicarboxylic acids, and esters [4–
10]. In the present project we have synthesised and charac-
terised the [Pt(DEEN)Cl2] and [Pd(DEEN)Cl2]c o m p l e x e s .
The thermodynamic behaviour of the Pd(II) complex was
investigated. The amine investigated has two ethyl groups
attached to one nitrogen atom of ethylenediamine. The two
ethyl groups will create steric hinderence with the incoming
ligand as DNA. This will tune the reactivity of the complex
to be similar to the antitumour platinum-amine complex.
The equilibrium studies are conducted at 37
◦C and ionic2 Bioinorganic Chemistry and Applications
strength 0.16M. This condition is similar to what is exist
in biological ﬂuids. The sulphur ligands as cysteine or glu-
tathione have high aﬃnity for Pd(II) and Pt(II) complexes.
These ligands will compete with the DNA for the reaction
with any antitumour agent. Therefore, it is of biological
signiﬁcance to evaluate the equilibrium constants for the
displacement reaction of model ligands as inosine, glycine,
or methionine by cysteine. These equilibrium constants may
give a measure of the eﬀectiveness of the antitumour agent.
2. Experimental
2.1. Materials. K2PdCl4,K 2PtCl4, N,N-diethylethylendia-
mine, and cyclobutanedicarboxylic acid were obtained
from Aldrich. The amino acids and related compounds
(glycine, alanine, β-alanine, γ-aminobuteric acid, β-phenyl-
alanine,valine,proline,hydroxyproline,iso-leucine,ethanol-
amine· HCl, serine, histidine, histamine dihydro-chloride,
ornithine, lysine, cysteine, methionine, threonine, S-
methylcysteine, aspartic acid glutamic acid, and methyl-
amine·HCl) were provided by Sigma Chemical Co. The
peptides used (glycinamide, glycylglycine, glycylleucine,
asparagines, and glutamine) and the dibasic acids used
(cyclobutane dicarboxylic acid, malonic acid, oxalic acid,
succinicacid,adipicacid,andfumaricacid)wereallprovided
byBDH-BiochemicalsLtd,Poole,UK.TheDNAconstituents
(inosine, inosine 5 -monophosphate, adenine, guanosine,
guanosine 5 -monophosphate, adenosine, cytosine,thymi-
dine, cytidine 5 -monophosphate, uracil, and uridine
5 -monophosphate) were provided by Sigma Chemical Co.
S-methylcysteine methyl ester was obtained from Sigma
Chem. Co. For equilibrium studies, [Pd(DEEN)Cl2]w a s
converted into the diaqua complex by treating it with two
equivalents of AgNO3 as described before [11]. The ligands
in the form of hydrochlorides were converted into the
corresponding hydronitrates. Cytosine, guanosine, and the
nucleotides were prepared in the protonated form with
standard HNO3 solution. All solutions were prepared in
deionized water.
2.2. Synthesis. [Pd(DEEN)Cl2] was prepared by dissolving
K2PdCl4 (2.82mmol) in 10mL water with stirring. The clear
solution of [PdCl4]
2− was ﬁltered, and N,N-diethylethyl-
enediamine (2.82mmol), dissolved in 10mL H2O, was
added dropwise to the stirred solution. The pH was adjusted
to 2-3 by the addition of HCl and/or NaOH. A yellowish-
brown precipitate of [Pd(DEEN)Cl2] was formed and stirred
for a further 30 minute at 50
◦C. After ﬁltering oﬀ the
precipitate, it was thoroughly washed with H2O, ethanol,
anddiethylether.Ayellowpowderwasobtained.Anal.Calcd.
for C6H16N2PdCl2: C, 24.54; H, 5.45; N, 9.54. Found: C,
24.51; H, 5.46; N, 9.44. The IR spectrum of Pd(DEEN)Cl2
exhibits strong NH absorption band in the range 3113-
3207cm−1. δ (NH) bands are observed at 1580–1609cm−1.
The Pd-N absorption was detected at 439cm−1. The chloro
complexwasconvertedintothecorrespondingaquacomplex
in solution by addition of two equivalents of AgNO3, heating
to 40–50
◦C for 3 hours, and removing the precipitated AgCl
by ﬁlteration.
[Pt(DEEN)Cl2] was prepared by dissolving K2PtCl4
(2mmol) in 10mL water with stirring. The clear solution
of [PtCl4]
2- was ﬁltered, and N,N-diethylethylenediamine
(2mmol), dissolved in 10mL water, was added dropwise
to the stirred solution. The solution mixture was reﬂuxed
at 70
◦C for 6 hours. The solution is evaporated to 5mL.
A yellow precipitate of [Pt(DEEN)Cl2]i sf o r m e d .T h e
precipitateisﬁltered,thoroughlywashedwithwater,ethanol,
and diethylether. Anal. Calcd for C6H16N2PtCl2 · H2O: C,
17.99; H,4.50; N, 7.00. Found: C, 18.69; H,4.24; N, 6.95%.
The IR spectrum of [Pt(DEEN)Cl2.H2O] exhibits strong
bands (H2O) in the range 3479-3544cm−1,s t r o n gN H
absorption band in the range 3128–3239cm−1. δ (NH) band
is observed at 1608cm−1. The Pt-N absorption was detected
at 441cm−1.
2.3. Apparatus. Potentiometric titrations were performed
with a Metrohm 686 titroprocessor equipped with a 665
Dosimat. The titroprocessor and electrode were calibrated
with standard buﬀer solutions, prepared according to NBS
speciﬁcation [12]. All titrations were carried out at 37.0 ±
0.1
◦C in puriﬁed nitrogen atmosphere using a titration
vessel described previously [13]. IR spectra were measured
ona8001-PCFT-IRShimadzuspectrophotometerusingKBr
pellets.
2.4. Procedure and Measuring Technique. The acid dissocia-
tion constants of the ligands were determined by titrating
1.00mmol samples of each with standard NaOH solutions.
Ligands were converted into their protonated form with
standard HNO3 solutions. The acid dissociation constants
of the coordinated water molecules in [Pd(DEEN)(H2O)2]
2+
were determined by titrating 1.00mmol of complex with
standard 0.05M NaOH solution. The formation constants
of the complexes were determined by titrating solution
mixtures of [Pd(DEEN)(H2O)2]
2+ (1.00mmol) and the
ligand in the concentration ratio of 1 : 1 for amino acids,
peptides, and dicarboxylic acids and in the ratio of 1 : 2
(Pd:ligand) for the DNA constituents. The titrated solution
mixtures each had a volume of 40mL, and the titrations
were carried out at 37
◦C and 0.1M ionic strength (adjusted
withNaNO3).Astandard0.05MNaOHsolutionwasusedas
titrant. The pH metre readings were converted to hydrogen
ion concentration by titrating a standard HNO3 solution
(0.01M), the ionic strength of which was adjusted to 0.1M
with NaNO3, with standard NaOH (0.05M) at 37
◦C.The
pH was plotted against p[H]. The relationship pH-p[H] =
0.05 was observed.
The species formed were characterized by the general
equilibrium
pM + qL+ rH  (M)p(L)q(H)r,( 1 )
for which the formation constants are given by
βpqr =

(M)p(L)q(H)r

[M]
p[L]
q[H]
r ,( 2 )Bioinorganic Chemistry and Applications 3
Table 1: Formation constants for complexes of [Pd(DEEN)(H2O)2 ]2+ with amino acids at 37
◦C and 0.16 M ionic strength.
Ligand MLH
a logβb Ligand M L H
a logβb
OH− 10−1 −5.11(0.01) Glycine 0 1 1 9.20(0.02)
10−2 −14.80(0.02) 0 1 2 11.20(0.03)
20−2 −7.20(0.04) 1 1 0 10.33(0.02)
Alanine 0 1 1 9.27(0.01) β-Phenylalanine 0 1 1 9.12(0.01)
0 1 2 12.17(0.02) 0 1 2 11.01(0.03)
1 1 0 10.16(0.02) 1 1 0 9.86(0.02)
γ-Aminobutyric acid 0 1 1 9.63(0.00) β-Alanine 0 1 1 9.70(0.02)
0 1 2 13.10(0.02) 0 1 2 13.20(0.03)
1 1 0 7.61(0.02) 1 1 0 9.50(0.02)
Valine 0 1 1 9.01(0.01) Proline 0 1 1 10.06(0.01)
0 1 2 11.48(0.02) 0 1 2 11.81(0.05)
1 1 0 9.90(0.03) 1 1 0 10.51(0.10)
Iso-Leucine 0 1 1 9.46(0.01) Histamine 0 1 1 9.34(0.01)
0 1 2 11.74(0.02) 0 1 2 15.20(0.02)
1 1 0 10.40(0.02) 1 1 0 12.85(0.08)
Histidine 0 1 1 8.84(0.01) Ethanolamine 0 1 1 9.16(0.01)
0 1 2 14.74(0.02) 1 1 0 6.99(0.02)
0 1 3 16.81(0.06) 1 2 0 12.00(0.04)
1 1 0 13.37(0.01) 1 1 -1 2.01(0.04)
1 1 1 16.32(0.03) (pk
H = 4.98)
Serine 0 1 1 8.59(0.01) Threonine 0 1 1 8.79(0.01)
0 1 2 10.95(0.02) 0 1 2 10.85(0.02)
1 1 0 10.01(0.01) 1 1 0 9.98(0.07)
1 1-1 2.04(0.02) 1 1-1 2.10(0.08)
(pk
H = 7.97) (pk
H = 7.88)
Ornithine 0 1 1 9.81(0.02) Lysine 0 1 1 9.90(0.02)
0 1 2 18.16(0.02) 0 1 2 18.80(0.03)
0 1 3 20.01(0.03) 0 1 3 21.00(0.03)
1 1 0 12.90(0.05) 1 1 0 10.12(0.05)
1 1 1 20.10(0.04) 1 1 1 18.70(0.02)
Aspartic acid 0 1 1 9.31(0.02) Glutamic acid 0 1 1 9.34(0.02)
0 1 2 12.79(0.03) 0 1 2 13.15(0.03)
0 1 3 14.50(0.03) 0 1 3 15.73(0.05)
1 1 0 8.53(0.03) 1 1 0 8.70(0.03)
1 1 1 11.92(0.04) 1 1 1 11.87(0.02)
S-methylcysteine methyl ester 0 1 1 8.51(0.02) Methionine 0 1 1 8.76(0.02)
0 1 2 10.40(0.02) 0 1 2 11.00(0.03)
1 1 0 9.51(0.01) 1 1 0 9.32(0.04)
Hydroxyproline 0 1 1 9.20(0.01) Methylamine 0 1 1 9.32(0.01)
0 1 2 11.00(0.02) 1 1 0 7.11(0.06)
1 1 0 9.91(0.03) 1 2 0 12.53(0.04)4 Bioinorganic Chemistry and Applications
Table 1: Continued.
Ligand MLH
a logβb Ligand M L H
a logβb
Cysteine 0 1 1 10.00(0.01)
0 1 2 18.21(0.02)
0 1 3 19.62(0.02)
1 1 0 14.11(0.03)
18.20(0.04)
aM, L, and H are the stoichiometric coeﬃcients corresponding to Pd(DEEN), amino acid, and H+,r e s p e c t i v e l y ;t h ec o e ﬃcient –1, refers to a proton loss.
blog β of Pd(DEEN)-amino acids. Standard deviations are given in parentheses; sum of square of residuals are less than 5E-7, pKH = logβ110 −logβ11-1.
Table 2: Formation constants for complexes of [Pd(DEEN)(H2 O)2]2+ with peptides, dibasic acids, and DNA units at 37
◦C and 0.16M
ionic strength.
Ligand M L H
a logβb Ligand M L H
a logβb
Glycinamide Cyclobutane-1,1- dicarboxylic acid
0 1 1 7.50(0.02) 0 1 1 5.37(0.01)
1 1 0 7.81(0.02) 0 1 2 8.17(0.01)
1 1-1 4.16(0.01) 1 1 0 6.11(0.02)
(pk
H = 3.65) 1 1 1 7.76(0.05)
Glycylglycine Succinic acid
0 1 1 7.77(0.01) 0 1 1 5.24(0.02)
0 1 2 10.81(0.01) 0 1 2 9.17(0.03)
1 1 0 7.71(0.01) 1 1 0 4.21(0.00)
1 1-1 2.61(0.08) 1 1 1 9.16(0.01)
Aspargine Malonic acid
0 1 1 8.35(0.01) 0 1 1 5.01(0.02)
0 1 2 10.51(0.03) 0 1 2 7.65(0.03)
1 1 0 9.30(0.02) 1 1 0 5.68(0.02)
11 - 1 −0.50(0.04) 1 1 1 8.15(0.06)
(pk
H = 9.80)
Glycylleucine Adipic Acid
0 1 1 7.91(0.01) 0 1 1 5.25(0.03)
1 1 0 7.35(0.03) 0 1 2 9.14(0.04)
1 1-1 1.98(0.08) 1 1 0 3.98(0.00)
(pk
H = 5.37) 1 1 1 8.26(0.00)
Glutamine Oxalic acid
0 1 1 8.77(0.01) 0 1 1 3.76(0.02)
0 1 2 10.78(0.02) 0 1 2 5.37(0.03)
1 1 0 9.40(0.02) 1 1 0 5.84(0.07)
11 - 1 −1.40(0.05) 1 1 1 8.06(0.07)
(pk
H = 10.80)
Inosine Fumaric acid
0 1 1 8.43(0.02) 0 1 1 4.27(0.04)
1 1 0 7.38(0.03) 0 1 2 6.63(0.04)
1 2 0 10.64(0.05) 1 1 0 4.23(0.04)
1 1 1 11.89(0.05) 1 1 1 7.74(0.06)Bioinorganic Chemistry and Applications 5
Table 2: Continued.
Ligand M L H
a logβb Ligand M L H
a logβb
Inosine-5 -monophosphate Cytidine-5 -monophosphate
0 1 1 8.83(0.02) 0 1 1 6.12(0.02)
0 1 2 15.07(0.03) 0 1 2 10.42(0.03)
1 1 0 8.18(0.03) 1 1 0 5.59(0.07)
1 2 0 13.35(0.04) 1 2 0 8.37(0.09)
1 1 1 13.93(0.04) 1 1 1 10.66(0.05)
Adenine Uridine-5 -monophosphate
0 1 1 9.29(0.03) 0 1 1 9.23(0.01)
0 1 2 13.32(0.04) 0 1 2 15.12(0.02)
1 1 0 9.17(0.11) 1 1 0 9.14(0.01)
1 2 0 13.77(0.02) 1 2 0 13.82(0.02)
1 1 1 18.36(0.02) 1 1 1 15.15(0.04)
Cytosine Uracil
0 1 1 4.45(0.02) 0 1 1 8.98(0.01)
1 1 0 5.68(0.03) 1 1 0 8.33(0.04)
1 2 0 8.51(0.04) 1 2 0 13.70(0.08)
Guanosine Guanosine-5 -monophosphate
0 1 1 8.91(0.01) 0 1 1 9.18(0.02)
0 1 2 11.01(0.02) 0 1 2 15.12(0.03)
1 1 0 10.18(0.06) 1 1 0 9.03(0.06)
1 2 0 18.88(0.06) 1 2 0 13.44(0.19)
1 1 1 15.06(0.01)
Adenosine Thymidine
0 1 1 3.40(0.01) 0 1 1 9.28(0.04)
1 1 0 2.74(0.04) 1 1 0 8.05(0.08)
1 2 0 5.15(0.00) 1 2 0 13.22(0.04)
aM,La n dHa r et h es t o i c h i o m e t r i cc o e ﬃcients corresponding to Pd(DEEN), ligands,and H+,r e s p e c t i v e l y ;t h ec o e ﬃcient –1 refers to a proton loss.
blog β of Pd(DEEN)- ligands. Standard deviations are given in parentheses; sum of square of residuals are less than 5e−7,pKH = log β110 −log β11-1.
where M, L, and H stand for [Pd(DEEN)(H2O)2]
2+ ion,
ligand, and proton, respectively. The calculations were
performed using the computer program [14] MINIQUAD-
75. The stoichiometry and stability constants of the com-
plexes formed were determined by trying various possible
composition models for the systems studied. The model
selected was that which gave the best statistical ﬁt and
was chemically consistent with the magnitudes of various
residuals, as described elsewhere [14]. Tables 1 and 2 list the
stability constants together with their standard deviations
and the sum of the squares of the residuals derived from
the MINIQUAD output. The concentration distribution
diagrams were obtained with the program SPECIES [15]
under the experimental condition used.
The hydrolysis kinetics of the complex ester was mon-
itored by pH-stat technique, [13, 16, 17] by using the
titroprocessor operating in the SET mode. The hydrolysis
was investigated using an aqueous solution (40mL) con-
taining a mixture of [Pd(DEEN)(H2O)2]
2+ (1mmol) and S-
methylcysteine methyl ester (1mmol), and the ionic strength
was adjusted to 0.16M with NaNO3. The pH of the mixture
was progressively raised to the desired value. The reaction
was monitored by addition of NaOH solution to maintain
Table 3: Kinetic data for hydrolysis of [Pd(DEEN)(cysteine methyl
ester)]2+ at 25
◦C and 0.1M ionic strength.
pH [OH
−]/Mk obs/s−1
8.8 7.59E − 06 4.95E − 04
9.0 1.20E − 05 7.67E − 04
9.2 1.91E − 05 1.39E − 03
9.4 3.02E − 05 1.88E − 03
9.6 4.79E − 05 3.36E − 03
Table 4: Kinetic data for the hydrolysis of [Pd(DEEN)(cysteine
methyl ester)]2+ at 25
◦C and 0.1M ionic strength.
kOH ko kOH(ester)a kOH/kOH(ester)
M
−1s−1 s−1 M
−1s−1
6.98E +01 9.270E −07 0.767 9.10E +01
aData taken from [16, 17]
the given pH. The data ﬁtting was performed with the
OLIS KINFIT set of programs [18] as described previously
[19, 20].6 Bioinorganic Chemistry and Applications
3. Results andDiscussion
The acid dissociation constants of the ligands were deter-
mined under the experimental conditions 37
◦C and con-
stant 0.16M ionic strength (adjusted with NaNO3), which
were also used for determining the stability constants of the
Pd(II) complexes.
3.1. The Hydrolysis of [Pd(DEEN) (H2O)2]2+. The
[Pd(DEEN)(H2O)2]
2+ ion may undergo hydrolysis. Its
acid-base chemistry was characterized by ﬁtting the
potentiometric data to various acid-base models. The
best-ﬁt model was found to be consistent with the formation
of three species: 10-1, 10-2, and 20-2, as given in reactions
(3)–(5). Trials were made to ﬁt the potentiometric data
assuming the formation of the monohydroxo-bridged
dimer, 20-1, but this resulted in a very poor ﬁt to the data.
The dimeric species 20-2 was detected by Nagy and S´ ov´ ag´ o
[21], for a similar system:
[Pd(DEEN)(H2O)2]
2+
100
Ka1
 [Pd(DEEN)(H2O)(OH)]
+
10-1
+H +,
(3)
[Pd(DEEN)(H2O)(OH)]
+
10-1
Ka2
 [Pd(DEEN)(OH)2]+H +
10-2
,
(4)
2[Pd(DEEN)(H2O)(OH)]
+
10-1
Kdimer
 [Pd(DEEN)(OH)2Pd(DEEN)]
2+
20-2
.
(5)
The pKa1 and pKa2 values for [Pd(DEEN)(H2O)2]
2+ are
5.11 and 9.69, respectively, The equilibrium constant for
the dimerization reaction (5) can be calculated by (6)a n d
amounts to 3.02:
logKdimer = logβ20-2 −2logβ10-1. (6)
The distribution diagram for [Pd(DEEN)(H2O)2]
2+ and
its hydrolyzed species is given in Figure 1 and reveals
that the concentration of the monohydroxo species 10-1,
and the dimeric species 20-2 increase with increasing pH,
predominate in the pH range 6–8, and reach a maximum
concentration of ∼50%. A further increase in pH is accom-
panied by an increase in the dihydroxo species (10-2), which
is the main species above pH∼10.0. This reveals that, in the
physiological pH range, that is, at pH 6-7, the monohydroxo
complex(10-1)predominatesandcaninteractwiththeDNA
subunits. At higher pH the inert dihydroxo complex will be
the major species, and consequently the ability of DNA to
bind the Pd(amine) complex will decrease signiﬁcantly.
3.2. Amino Acid Complexes. Analysis of the titration data
for the Pd(DEEN)-amino acid system showed the formation
of 1 : 1 species. Histidine, ornithine, lysine, glutamic acid,
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Figure 1: Concentration distribution diagram for the hydrolysis of
[Pd(DEEN)(H2O)2]
2+.
(100)
(110)
(11-1)
(10-1)
(10-2)
0
20
40
60
80
100
P
d
(
D
E
E
N
)
2
+
(
%
)
2 3 4 5 6 7 8 9 10 11 12
pH
Figure 2: Concentration distribution diagram for various complex
species in Pd(DEEN)
2+-serine system.
aspartic acid, and cysteine form, in addition to 1 : 1
complexes, the monoprotonated species. The pka of the
protonated complex was calculated from (7):
pka = logβ111 − logβ110 (7)
The pka values of the protonated species are 2.95 for
histidine, 7.20forornithine,8.58forlysine,3.17forglutamic
acid and, 3.39 for aspartic acid. The stability constants of
the histidine, ornithine, and lysine complexes are higher
than those of simple amino acids. This indicates that these
amino acids coordinate via the two nitrogen centres, that is,
imidazole and amino groups in the case of histidine, and by
two amino groups in the case of ornithine and lysine. This is
in line with the strong aﬃnity of Pd(II) for nitrogen donor
centres. Aspartic acid and glutamic acid have two carboxylic
and one amino groups as potential binding centres. They
may coordinate either via the two carboxylate groups or by
the amino group and one carboxylate group. The stability
constants of their complexes are in the range of those of
amino acids. This may reveal that aspartic acid and glutamicBioinorganic Chemistry and Applications 7
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Figure 3: Concentration distribution diagram for various complex
species in Pd(DEEN)
2+ -glycylglycine system.
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Figure 4: Concentration distribution diagram for various complex
species in Pd(DEEN)
2+-succinic acid System.
acid coordinate via the amino and one carboxylate groups.
Serine and threonine have an extra binding centre on the β-
alcoholategroup.Thisgroupwasreported[22]toparticipate
in metal complex formation. The potentiometric data is
much better ﬁtted assuming the formation of the complex
species 110 and 11-1. This reveals that the β-alcoholate
group participates in complex formation through induced
ionization of the alcoholic group forming the species 11-
1. The pk
H value of the β-alcoholate incorporated in the
Pd(II)complex(logβ110−logβ11-1)is7.97and7.88forserine
and threonine, respectively. Also, ethanolamine forms the
complex species 110, 120, and 11-1, and the logβ110 value for
ethanolamine complex is smaller than that for amino acids.
This may be due to the coordination of ethanolamine at low
pHoccurringthroughtheaminoandneutralalcoholgroups,
while in the case of serine and threonine the coordination
is through amino and carboxylate groups. At high pH,
the hydroxyl group is coordinated and undergoes induced
ionization forming the species 11-1. The pk
H value of the
coordinated alcohol group in ethanolamine (4.98) is smaller
than that of serine and threonine. This is consistent with the
reaction scheme where the alcohol group in ethanolamine is
coordinated with the Pd(DEEN)
2+, while the alcohol group
in serine and threonine is competing with the carboxylate
group in binding to Pd(DEEN)
2+ ion. Due to coordination
of the alcohol group by donation of the electron pair on the
oxygen to the metal centre, the OH bond is considerably
weakened, and thus the ionization of a proton occurs at a
lower pH.
The distribution diagram for the serine complex, given
in Figure 2, shows that the complex species with coeﬃcients
110 reaches the maximum degree of formation (∼97%) at
pH5.0to6.0,thatis,inthephysiologicalpHrange.However,
the species 11-1 predominates after pH 8.5 and attains the
maximum concentration of ∼98% at pH ∼9.5.
3.3. Peptide Complexes. The potentiometric data for the
peptide complexes were ﬁtted on the basis of formation of
the complexes with stoichiometric coeﬃcients 110 and 11-1
according to the following equilibria, where HL is peptide:
[Pd(DEEN)(H2O)2]
2++L
−
100
K
 [Pd(DEEN)L]
++2 H 2O
110
,
[Pd(DEEN)L]
+
110
KH
 [Pd(DEEN)LH−1]+H +
11-1
.
(8)
The 110 complex is formed via coordination of the
amine and carbonyl groups. On increasing the pH, the
coordination site should switch from the carbonyl oxygen
to the amide nitrogen with release of the amide hydrogen
forming the complex [Pd(DEEN)(LH−1)]. Such changes in
coordination centres are now well documented [23]. The
pKH values of the amide groups incorporated in the Pd(II)
complexes (logβ110 − logβ11-1) are in the 3.65–10.80 range.
It is noteworthy that the pKH for glycinamide complex is
lowerthanthatofotherpeptides. Thissigniﬁesthatthemore
bulky substituent group on the peptide may serve to hinder
the structural change in going from the protonated to the
deprotonated complexes. The pKH of the glutamine complex
is markedly higher than that for other peptide complexes.
This is ascribed to the formation of a seven-membered
chelate ring, which would probably be more strained and
therefore less favoured.
T h er e l a t i v em a g n i t u d eo ft h ep K H values of the Pd(II)
complexes with peptides has interesting biological impli-
cations. Under normal physiological conditions (pH 6-7)
the peptide would coordinate to [Pd(DEEN)(H2O)2]
2+ in
entirely diﬀerent fashions. Glutaminate would exist solely
in the protonated form, whereas the other peptides would
be present entirely in the deprotonated form. In addition,
the slight diﬀerence in the side chain of the peptides
produces dramatic diﬀerences in their behaviour towards the
palladium species. The speciation diagram of glycylglycine
complex is given in Figure 3. The Pd(DEEN)(L)
+ (110)
species starts to form at pH 2.0 and with increasing of pH,
its concentration increases reaching the maximum of 70% at
pH 4.3. Further increase of pH is accompanied by a decrease
in Pd(DEEN)(L)
+ complex concentration and an increase of
Pd(DEEN)(LH−1) complex formation.8 Bioinorganic Chemistry and Applications
[Pd(DEEN)(H2O)2]2++N H 2CH(R)COOR’ [Pd(DEEN)(NH2CH(R)COOR’)]
[Pd(DEEN)(NH2CH(R)COO)]
2++ 2H2O
Kf
KOH OH–
+ R’OH +
Scheme 1
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3.4. Dicarboxylic Acid Complexes. In the Pd(DEEN)-
dicarboxylic acid system, the results showed the presence
of the 1 : 1 species and its protonated form. The results
in Table 2 show that the adipic acid complex is the least
stable as the complex involves the formation of the least
stable eight-membered chelate ring. The pKa values of the
protonated species for [Pd(DEEN)HL]
+ are in the range 1.65
– 4.95. These values are lower than those for the HL
− ion see
Table 2. The lowering of the pKa is due to acidiﬁcation of the
second carboxylic acid group upon coordination of Pd(II) to
one carboxylate group [24].
From the concentration distribution diagram of the
succinic acid complex, given in Figure 4, it is interesting to
note that the monoprotonated species attains its maximum
concentration of 58% at pH 3.8. This form has one coordi-
nation site available for binding to DNA. Such species was
documented to be the active form in the case of carboplatin
[25].
3.5. DNA Complexes. DNA constituents, such as adenosine,
cytosine, uracil, and thymidine, form 1 : 1 and 1 : 2
complexes with the Pd(DEEN)
2+ ion. However, inosine,
adenine and nucleotides such as inosine-5 -monophosphate,
guanosine-5 -monophosphate, cytidine-5 -monophosphate
and uridine-5 -monophosphate, form the monoprotonated
complex, in addition to the formation of 1 : 1 and 1 : 2
complexes. The pKa value of the protonated inosine complex
is 4.51. This value corresponds to N1H. The lowering of this
value with respect to that of free inosine (pKa = 8.43) is
due to acidiﬁcation upon complex formation [26]. The pKa
values of the protonated nucleotide complexes are 5.75, 6.03,
5.07, and 6.01 for inosine-5 -monophosphate, guanosine-5 -
monophosphate, cytidine-5 -monophosphate, and uridine-
5 -monophosphate respectively.
The pyrimidines uracil, uridine-5 -monophosphate,
thymidine-5,-monophosphate, and thymidine have basic
nitrogen donor atoms (N3)
26 as a result of the high pKa
values of pyrimidines (pKa > 9), and the complexes formed
predominates above pH 8.5. Both cytosine and cytidine-
5 -monophosphate undergo N27
3 protonation under mild
acidic conditions. The values obtained for their protonation
constants are 4.45 and 6.12, respectively. The lower values of
the stability constants of their complexes, Table 2, reﬂect the
diﬀerence in the basicity of the donor site.
It was shown above that N-donor ligands such as
DNA constituents have aﬃnity for [Pd(DEEN)(H2O)2]
2+,
which may have important biological implications since
the interaction with DNA is thought to be responsible for
the antitumour activity of related complexes. However, the
preference of Pd(II) to coordinate to S-donor ligands was
demonstrated as shown in Tables 1 and 2. These results
suggest that Pd(II)-N adducts can easily be converted into
Pd-S adducts [27]. Consequently, the equilibrium constant
for such conversion is of biological signiﬁcance. Consider
inosine as a typical DNA constituent (presented by HA) and
cysteine as a typical thiol ligand (presented by H2B). The
equilibria involved in complex-formation and displacement
reactions are
HA  H+ +A
−,
H2B  2H+ +B 2−,
[Pd(DEEN)(H2O)2]
2+ +A
−  [Pd(DEEN)A]
+ +2 H 2O
(100)( 110)
,
(9)
β
[Pd(DEEN)A]+
110 =

Pd (DEEN)A+
[Pd(DEEN)(H2O)2]
2+
A
−, (10)
[Pd(DEEN)(H2O)2]
2+ +B 2−  [Pd(DEEN)B]+2 H 2O
100 110
,
(11)
β
[Pd(DEEN)B]
110 =
[Pd(DEEN)B]
[Pd(DEEN)(H2O)2]
2+
B2−
 (12)
[Pd(DEEN)(A)]
+ +B 2−
Keq
 [Pd(DEEN)(B)]+A
− (13)
Theequilibriumconstantforthedisplacementreactiongiven
in (13)i sg i v e nb y
Keq =
[Pd(DEEN)(B)]

A
−

Pd(DEEN)(A)
+
B2−
. (14)Bioinorganic Chemistry and Applications 9
Substitution from (10)a n d( 12)i n( 14) results in:
Keq =
β
[Pd(DEEN)B]
110
β
[Pd(DEEN)A]
+
110
(15)
where logβ110 values for [Pd(DEEN)(A)]
+ and
[Pd(DEEN)B] complexes taken from Table 2 amount
to 7.38 and 14.11, respectively, and by substitution in (15)
results in logKeq = 6.73. In the same way the equilibrium
constants for the displacement of coordinated inosine
by glycine and methionine are logKeq = 2.95 and 1.94,
respectively. These values clearly indicate how sulfhydryl
ligands such as cysteine and, by analogy, glutathione
are eﬀective in displacing the DNA constituent, that
is, the main target in tumour chemotherapy. Chelated
cyclobutanedicarboxylate may undergo displacement
reaction with inosine. logKeq for such a reaction was
calculated as described above and amounts to 1.27. The
low value of the equilibrium constant for the displacement
reaction of coordinated cyclobutanedicarboxylate by inosine
is of biological signiﬁcance since it is in line with the ﬁnding
that carboplatin interacts with DNA through ring opening of
chelated CBDCA and not through displacement of CBDCA.
3.6. Kinetics of Hydrolysis of Amino Acid Esters. The hydrol-
ysis of amino acid esters can be presented as shown in
Scheme 1.
The equilibrium constant for S-methylcysteine methyl
ester (Kf)i ss u ﬃciently large that coordination of the ester
is readily accomplished. The kinetic data, name, the volume
of base added to keep the pH constant versus time, could
be ﬁtted by a single exponential function. A plot of kobs
versus hydroxide ion concentration is linear and follows the
rate expression kobs = ko +k OH[OH
−], where ko represents
the rate constant for the water-catalyzed pathway and kOH
the rate constant for the base-catalyzed pathway, the kinetic
data are given in Table 3. The linear dependence of the
rate constant on the OH
− concentration is consistent with
direct attack of OH
− ion on the ester carbonyl group. The
catalysis ratio C = kOH/kOHester, where kOHester represents
the rate constant for the hydrolysis of the free amino acid
ester, is given in Table 4. The catalysis ratio for coordinated
cysteine methyl ester equals 91.0. A catalysis ratio of such
low value is consistent with the structural formula for the
mixed-ligandcomplex,inwhichthereisnodirectinteraction
between the Pd
II ion and the ester carbonyl group. The
relatively low catalysis ratio is probably due to activation
by induction through the coordinated nitrogen atom as
reported previously [28, 29].
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